Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
Emanuele Pontali, Stefano Volpi, Giancarlo Antonucci, Marco Castellaneta, Davide Buzzi, F E Tricerri, Alessia Angelelli, Roberta Caorsi, Marcello Feasi, Francesca Calautti, Elio Castagnola, Gian Andrea Rollandi, Angelo Ravelli, Giovanni Cassola, Marco Gattorno
Topics & Concepts
AnakinraCoronavirus disease 2019 (COVID-19)MedicineDisease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)LungLung diseaseInternal medicineGastroenterologyVirologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesRespiratory Support and MechanismsLong-Term Effects of COVID-19